tradingkey.logo

BRIEF-Tandem Diabetes Care Announces FDA Clearance Of Control-IQ+ Automated Insulin Delivery Tech

ReutersFeb 25, 2025 2:39 PM

- Tandem Diabetes Care Inc TNDM.O:

  • TANDEM DIABETES CARE ANNOUNCES FDA CLEARANCE OF CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY FOR PEOPLE WITH TYPE 2 DIABETES

  • TANDEM DIABETES CARE INC: CONTROL-IQ+ IS EXPECTED TO BE AVAILABLE FOR NEW AND EXISTING CUSTOMERS IN UNITED STATES IN MARCH 2025

Source text: ID:nBw934rdga

Further company coverage: TNDM.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI